Christopher C. Thompson, MD, MSc
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Christopher C. Thompson, MD, MSc sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
Christopher C. Thompson, MD, MSc: 5 sponsored US clinical trials, 5 recruiting.
Christopher C. Thompson, MD, MSc sponsors 5 registered US clinical trials on ClinicalTrials.gov, 5 of them currently recruiting. The most-studied condition in this pipeline is Obesity, Morbid, with 2 trials.
Upper-quartile sponsor footprint
Christopher C. Thompson, MD, MSc sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
5 total, page 1 of 1
Trans-nasal Endoscopy for Bariatric Patients
NCT06200961
Necrosectomy With Cryotechnology for Accelerated Removal
NCT06553651
H. Pylori Eradication With Argon Plasma During Endoscopy
NCT06529159
Marginal Ulcer Healing With Low-Thermal Argon Plasma Endoscopic Treatment
NCT06543316
Efficacy and Safety of Endoscopic Antral Myotomy as a Novel Weight Loss Procedure
NCT05711758
What is open in the Christopher C. Thompson, MD, MSc pipeline
5 recruiting of 5 indexed (100% open).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Obesity, Morbid (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Christopher C. Thompson, MD, MSc: open-pipeline peers nationwide
Peers matched on 5 registered trials and 100% open enrollment, not the therapeutic-area sidebar.
Christopher C. Thompson, MD, MSc sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 trials (± recruiting share)
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors near 100% open enrollment (± trial volume)
- AAVantgarde Bio Srl · 100% recruiting · 2 trials
- Acorn Biolabs · 100% recruiting · 3 trials
- Acrivon Therapeutics · 100% recruiting · 2 trials
- ADARx Pharmaceuticals · 100% recruiting · 4 trials
Related
What to do with this Christopher C. Thompson, MD, MSc page
5 registered trials is a research-attention snapshot, not an endorsement of Christopher C. Thompson, MD, MSc or any single study.
- 5 of Christopher C. Thompson, MD, MSc's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity, Morbid is the condition Christopher C. Thompson, MD, MSc studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity, Morbid trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Christopher C. Thompson, MD, MSc pipeline card: 5 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.